Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
| Autor: | Chiorean EG, Von Hoff DD, Tabernero J, El-Maraghi R, Wee Ma W, Reni M, Harris M, Whorf R, Liu H, Shiansong Li J, Manax V, Romano A, Lu B, Goldstein D |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | British journal of cancer [Br J Cancer] 2016 Oct 25; Vol. 115 (9), pp. e13. Date of Electronic Publication: 2016 Sep 22. |
| DOI: | 10.1038/bjc.2016.306 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink